VanEck Biotech ETF (BBH)

BATS BZX Real-Time Price
As of 10:20am ET
 +1.46 / +1.02%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS  US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.


1 month-10.91% 3 years+7.15%
3 months-5.73% 5 years+4.97%
1 year-17.58% Since inception+14.97%
Data through 05/18/2022

Quote Details

Previous close$142.87
Open day’s range144.33 – 144.33
Net asset value (NAV)143.12 (05/18/2022)
Daily volume80
Average volume (3 months)25,114
Data as of 10:20am ET, 05/19/2022

Peer Comparisonvs. Health ETFs

Performance 5-yr return+4.97%+11.31%
Expense Gross exp ratio0.35%1.00%
Risk 5 year sharpe ratio0.240.52
Net assets$439.0M$1.9B
Average market cap$38.3B$41.8B
Average P/E14.725.8
Dividend / Share--0.26%


IEHS iShares Evolved U.S. Healthcare Staples ...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen13.88%
VRTX Vertex Pharmaceuticals Inc7.84%
GILD Gilead Sciences7.30%
REGN Regeneron Pharmaceuticals6.90%
MRNA Moderna Inc6.58%
IQV IQVIA Holdings Inc5.17%
ILMN Illumina Inc4.91%
BIIB Biogen4.80%
BNTX BioNTech SE4.29%
TECH Bio-Techne Corp4.12%